Form 8-K - Current report:
SEC Accession No. 0001193125-19-185967
Filing Date
2019-06-28
Accepted
2019-06-28 16:01:57
Documents
3
Period of Report
2019-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d25475d8k.htm 8-K 33662
2 EX-99.1 d25475dex991.htm EX-99.1 129817
3 EX-99.2 d25475dex992.htm EX-99.2 60293
  Complete submission text file 0001193125-19-185967.txt   225092
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 19929198
SIC: 2834 Pharmaceutical Preparations